Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Stellate Ganglion Agnosia Facial Palsy Facial Paralysis Mouth Diseases Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pain Management Paralysis Pathological Conditions, Signs and Symptoms Perceptual Disorders Signs and Symptoms Stomatognathic Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

facial nerve palsy patients

Exclusion criteria

light of a recent myocardial infarction.
anticoagulant use
glucoma
lateral nerve palsy
emphysema
cardiac conduction abnormalities
active infection, flu, cold
uncontrolled cough
Fever
Very high blood pressure or if you are on blood thinners.
allergic reaction to local anesthetics
Primary and secondary coagulopathy.

Treatment and study plan

Stellate Ganglion Block

Drug

Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment

Primary outcomes

Primary outcome: Average motor conduction latency in six muscle of the face

Time frame: 6 month

Secondary outcomes

Improved muscle tone

Time frame: 6 months

facial muscles start to regain their strength improvement of muscle tone.

Study contacts

Contact information is provided by the study sponsor or research team.

Remonda Zaki Abd El Naeem

CONTACT

[email protected]

+201200184996

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Dec 19, 2024
Registry last updated: Dec 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting